Lorlatinib - PF-06463922

Status

APPROVED_FOR_MARKETING

Phases

Unknown

Study type

Expanded Access

Source

ClinicalTrials.gov

Registry ID

NCT03127618

Enrollment

Unknown

Registered

2017-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2020-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Lorlatinib expanded access program

DRUGLorlatinib

Age

18 Years to No maximum

* Adult, Senior

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026